U.S. federal trademark · Serial No. 50111336 · Reg. No. 848264
Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of mood disorders; pharmaceutical preparations for the treatment of depressive disorders; pharmaceutical preparations for the treatment of anhedonia; pharmaceutical preparations for the treatment of major depressive disorder (MDD); pharmaceutical preparations for the adjunctive treatment of major depressive disorder; pharmaceutical preparations for the treatment of bipolar disorder, post-traumatic stress disorder (PTSD), and attention-deficit / hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of central nervous system disorders
Providing medical information; providing medical information relating to treatment of major depressive disorder; providing medical information relating to treatment of psychiatric, mood, neurological, and central nervous system disorders
Pharmaceutical research and development services; medical and scientific research in the field of major depressive disorder; medical and scientific research in the field of psychiatric, mood, neurological, and central nervous system disorders; providing medical and scientific information in the field of pharmaceutical research and development
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.